logo
Analysts' Opinions Are Mixed on These Industrial Goods Stocks: Rolls-Royce Holdings (OtherRYCEF) and Boeing (BA)

Analysts' Opinions Are Mixed on These Industrial Goods Stocks: Rolls-Royce Holdings (OtherRYCEF) and Boeing (BA)

Companies in the Industrial Goods sector have received a lot of coverage today as analysts weigh in on Rolls-Royce Holdings (RYCEF – Research Report) and Boeing (BA – Research Report).
Confident Investing Starts Here:
Rolls-Royce Holdings (RYCEF)
Citi analyst Charles Armitage maintained a Hold rating on Rolls-Royce Holdings today and set a price target of £6.41. The company's shares closed last Friday at $12.00.
Armitage has an average return of 29.6% when recommending Rolls-Royce Holdings.
According to TipRanks.com, Armitage is ranked #229 out of 9627 analysts.
Currently, the analyst consensus on Rolls-Royce Holdings is a Strong Buy with an average price target of $11.59.
Boeing (BA)
RBC Capital analyst Kenneth Herbert maintained a Buy rating on Boeing today and set a price target of $230.00. The company's shares closed last Friday at $210.80.
According to TipRanks.com, Herbert is a top 25 analyst with an average return of 23.7% and a 72.2% success rate. Herbert covers the Industrial Goods sector, focusing on stocks such as Amentum Holdings, Inc., L3Harris Technologies, and Karman Holdings Inc.
Boeing has an analyst consensus of Strong Buy, with a price target consensus of $219.95, representing a 4.6% upside. In a report issued on May 26, UBS also upgraded the stock to Buy with a $226.00 price target.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Stocks to watch on August 18: M&M, Ashok Leyland, Tata Chemicals, HDFC Bank, BPCL, Max Healthcare and more
Stocks to watch on August 18: M&M, Ashok Leyland, Tata Chemicals, HDFC Bank, BPCL, Max Healthcare and more

Business Upturn

timean hour ago

  • Business Upturn

Stocks to watch on August 18: M&M, Ashok Leyland, Tata Chemicals, HDFC Bank, BPCL, Max Healthcare and more

Brokerage houses have released fresh updates and recommendations on key Indian stocks and sectors, which are likely to drive trading action today. Here are the highlights from fund house recommendations. Nomura has maintained a buy rating on Mahindra & Mahindra (M&M) with a target price of ₹3,736 per share, citing strong positioning in the SUV segment. On Ashok Leyland, BofA, Avendus and Motilal Oswal (MOSL) all maintained their buy calls with target prices of ₹146, ₹140, and ₹141 respectively, indicating continued optimism around the commercial vehicle cycle. Jefferies was more conservative, keeping a buy call but with a lower target price of ₹120, reflecting near-term constraints. Morgan Stanley (MS) retained an overweight stance on Tata Chemicals with a target price of ₹1,127, expecting the company to benefit from structural demand drivers. Jefferies reiterated its buy ratings on Aditya Birla Fashion & Retail (target ₹100), HDFC Bank (₹2,400), HDB Financial (₹900), BPCL (raised target ₹410), and Max Healthcare (₹1,500). It also maintained an underperform on Anupam Rasayan despite raising the target price to ₹625. In the financial space, Citi reiterated its buy on Shriram Finance with a target price of ₹750. On the macro front, the India ratings upgrade drew commentary from multiple brokerages. JP Morgan called it 'unambiguously positive' and a likely sentiment booster. Kotak Securities noted that the upgrade reflected fiscal consolidation and growth, though future improvements hinge on state finances. Citi said the earlier-than-expected move may not immediately trigger debt inflows, while UBS highlighted that it takes India one step above the lowest investment-grade and could benefit state-owned enterprises. On GST rate rationalisation, Jefferies expects the government to act in Q4CY25, noting $20 billion in savings from GST compensation provides the fiscal room. It said rate cuts may benefit cement, two-wheelers, consumer durables, insurance, garments, footwear, and passenger vehicles. Kotak estimated the move could deliver a ₹2.4 trillion demand boost, largely aiding autos and durables, while Citi said autos, consumer discretionary, staples, insurance and cement could see the highest impacts. Morgan Stanley added that autos remain key as they account for 14% of GST collections, with Hero, Eicher, Maruti and M&M positioned as beneficiaries. On Indian equities overall, Jefferies called India the best long-term structural story in Asia, while Morgan Stanley noted that thawing India-China ties could revive investments and supply chains. In other stock-specific views, UBS maintained a neutral on Vodafone Idea with a target of ₹8.5, while Citi kept a buy call at ₹10. UBS also maintained a neutral on Angel One (TP ₹2,935). MOSL retained a sell rating on Deepak Nitrite with a cut target of ₹1,630. With strong endorsements for autos, chemicals, financials and healthcare, along with optimism on GST reforms and the sovereign rating outlook, today's trading session is expected to see concentrated action in these names. Disclaimer: The brokerage views and target prices mentioned in this article are sourced directly from fund house and analyst reports. They are presented here for informational and news purposes only. Business Upturn does not provide investment advice or stock recommendations. Readers are advised to consult certified financial advisors before making any investment decisions. Ahmedabad Plane Crash News desk at

Analysts' Opinions Are Mixed on These Technology Stocks: Circle Internet Group, Inc. Class A (CRCL) and u-blox Holding AG (OtherUBLXF)
Analysts' Opinions Are Mixed on These Technology Stocks: Circle Internet Group, Inc. Class A (CRCL) and u-blox Holding AG (OtherUBLXF)

Business Insider

time9 hours ago

  • Business Insider

Analysts' Opinions Are Mixed on These Technology Stocks: Circle Internet Group, Inc. Class A (CRCL) and u-blox Holding AG (OtherUBLXF)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Circle Internet Group, Inc. Class A (CRCL – Research Report) and u-blox Holding AG (UBLXF – Research Report). Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Circle Internet Group, Inc. Class A (CRCL) Seaport Global analyst Jeff Cantwell reiterated a Buy rating on Circle Internet Group, Inc. Class A today and set a price target of $280.00. The company's shares closed last Friday at $149.26. According to Cantwell is a 5-star analyst with an average return of 11.7% and a 57.5% success rate. Cantwell covers the Technology sector, focusing on stocks such as ACI Worldwide, Fiserv, and Dave. The word on The Street in general, suggests a Hold analyst consensus rating for Circle Internet Group, Inc. Class A with a $174.64 average price target, implying a 23.7% upside from current levels. In a report issued on August 4, Bernstein also maintained a Buy rating on the stock with a $230.00 price target. u-blox Holding AG (UBLXF) Kepler Capital analyst Torsten Sauter maintained a Hold rating on u-blox Holding AG on August 15 and set a price target of CHF105.00. The company's shares closed last Friday at $170.79. According to Sauter is ranked #1974 out of 9981 analysts. The word on The Street in general, suggests a Hold analyst consensus rating for u-blox Holding AG with a $148.36 average price target, representing a -13.1% downside. In a report issued on August 7, UBS also maintained a Hold rating on the stock with a CHF105.00 price target.

Citi Raises PT on Pfizer Inc. (PFE) to $26; Maintains ‘Neutral' Rating
Citi Raises PT on Pfizer Inc. (PFE) to $26; Maintains ‘Neutral' Rating

Yahoo

time20 hours ago

  • Yahoo

Citi Raises PT on Pfizer Inc. (PFE) to $26; Maintains ‘Neutral' Rating

With strong hedge fund interest and a low price-to-earnings ratio, Pfizer Inc. (NYSE:PFE) secures a place on our list of the . A closeup shot of a laboratory technician handling a medical device used for fertility treatments. Following the company's strong Q2 performance, Citi raised its price target on Pfizer Inc. (NYSE:PFE) from $25 to $26 on August 6, 2025, maintaining a 'Neutral' rating. The analyst attributed the target revision to strong results. At the same time, Citi advised caution regarding continued policy uncertainties. Pfizer Inc. (NYSE:PFE) reported 10% revenue growth, taking total revenue to $14.7 billion. The top-line growth was driven by strong sales of the Vyndaqel product family, Comirnaty, Paxlovid, Padcev, Eliquis, and other products. At the quarter-end, the company also reiterated its 2025 revenue guidance of $61.0-$64.0 billion, while raising its adjusted diluted EPS outlook by $0.10 at the midpoint to $2.90-$3.10. This guidance raise was made despite challenges caused by the Inflation Reduction Act's Medicare Part D redesign. Pfizer Inc. (NYSE:PFE) discovers, develops, and markets biopharmaceutical products globally. It is included in our list of the most undervalued value stocks to buy. While we acknowledge the potential of PFE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store